Genelux (NASDAQ:GNLX) Now Covered by HC Wainwright

HC Wainwright assumed coverage on shares of Genelux (NASDAQ:GNLX – Free Report) in a research report report published on Monday, Marketbeat reports. The firm issued a buy rating and a $35.00 price target on the stock. HC Wainwright also issued estimates for Genelux’s Q4 2023 earnings at ($0.21) EPS, FY2023 earnings at ($1.17) EPS, FY2024 […]

Related Keywords

Aladar Szalay ,John Thomas ,Genelux Corporation ,Citigroup Inc ,Genelux Company Profile ,Charles Schwab Investment Management Inc ,Maxim Group ,Blackrock Inc ,Barclays Plc ,Tower Research Capital ,Free Report ,Capital Management ,Director John Thomas ,Research Capital ,Schwab Investment Management ,Get Free Report ,Genelux Daily ,Genelux ,Nasdaq Gnlx ,Gnlx ,Medical ,Initiated Coverage ,Hc Wainwright ,